F-1/A: Mingteng International Seeks to Raise $15 Million in Best Efforts Offering of Ordinary Shares and Pre-Funded Warrants
F-1/A Filing
Mingteng International Corporation Inc. announces a best efforts offering of up to 2,640,845 ordinary shares and/or pre-funded warrants, aiming to raise $15 million for general working capital and production expansion.
Summary
- Mingteng International Corporation Inc. is conducting a best efforts offering to sell up to 2,640,845 ordinary shares and/or pre-funded warrants.
- The assumed offering price is $5.68 per share, based on the last reported sale price on March 14, 2025.
- Pre-funded warrants are offered to purchasers whose ownership would exceed 4.99% of outstanding shares after the offering.
- The purchase price of each pre-funded warrant is the offering price per share minus $0.0001, which is the exercise price per share.
- The company expects to complete the offering within 60 business days following the commencement of sales.
- The net proceeds are estimated to be $13,490,250, after deducting placement agent commissions and offering expenses.
- The company intends to use the net proceeds for general working capital, production facilities purchase, and production scale expansion.
- Craft Capital Management LLC and R. F. Lafferty& Co., Inc. are acting as placement agents for the offering, receiving a commission of 6.5% of the gross proceeds.
- The company is required to submit a filing with the CSRC within three business days after the completion of the offering.
Sentiment
Score: 5
Explanation: The document presents a mixed sentiment. While it highlights growth strategies and established customer relationships, it also acknowledges significant risks, uncertainties, and a recent net loss, resulting in a neutral overall outlook.
Positives
- The company has established long-term business relationships with leading major customers in the automobile parts manufacturing industry.
- The company has registered 13 authorized utility model and invention patents in China.
- The company has received approval from the CSRC regarding completion of the required filing procedures for its initial public offering.
- The company has a management team with professional experience in the mold industry.
Negatives
- The public offering price for the Securities will be determined at the time of pricing and may be at a discount to the current market price at the time.
- The company's ordinary share price is volatile.
- The Chinese government exerts substantial influence over the manner in which the company must conduct its business activities.
- The company is subject to certain legal and operational risks associated with its operations in China.
- The company may become subject to a variety of laws and regulations in the PRC regarding privacy, data security, cybersecurity, and data protection.
- The company's Ordinary Shares may be prohibited from being traded on a national exchange under the HFCAA if the Public Company Accounting Oversight Board (the PCAOB) is unable to inspect the company's former and current auditors for two instead of three consecutive years beginning in 2021.
Risks
- The company's business is highly dependent on its reputation.
- Changes in the availability, quality, and cost of key raw materials could have a material adverse effect.
- The company's business is dependent on certain major customers.
- The company faces intense competition.
- The company will be dependent on dividends and other distributions from equity paid by its PRC Subsidiaries for its cash needs.
- You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited because the company is incorporated under Cayman Islands law.
- To the extent cash or assets in the business are in the PRC or Hong Kong or a PRC or Hong Kong entity, the funds or assets may not be available to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions and limitations on the ability of us or our subsidiaries by the PRC government to transfer cash or assets.
- The delisting of the company's Ordinary Shares, or the threat of being delisted, may materially and adversely affect the value of your investment.
Future Outlook
The company aims to strengthen its market position in China by expanding its lines of business, increasing production facilities, enhancing R&D capabilities, securing new customers, and optimizing production management.
Industry Context
The Chinese automotive mold manufacturing industry is rapidly developing with intense competition from both domestic and foreign enterprises. The company aims to strengthen its market position in China by expanding its lines of business, increasing production facilities, enhancing R&D capabilities, securing new customers, and optimizing production management.
Comparison to Industry Standards
- The document mentions competitors, including domestic and foreign companies, but does not provide specific details for a direct comparison to industry standards.
- The document mentions that the company is a supplier to a number of Chinese listed companies and has established long-term business relationships with leading major customers in the automobile parts manufacturing industry, most of whom have more than 5 years of business relationship with us.
- The document mentions that the company's indirect end users include many Chinese and foreign automobile enterprises and famous brands.
Related Party Transactions
- The company purchases processing services from Wuxi Kaiteng Mold Factory.
- The company has a loan from Jingzhu Ding to supplement the working capital of the company.
- The loan is non-interest bearing and the loan term is indefinite.
Stakeholder Impact
- Shareholders may experience dilution due to the offering.
- The company's ability to execute its growth strategies will impact stakeholders.
- The company's financial performance will affect shareholder value.
Next Steps
- The company will complete the offering within 60 business days following the commencement of sales.
- The company will remit the net proceeds to China.
- The company will use the net proceeds for general working capital, production facilities purchase, and production scale expansion.
- The company is required to submit a filing with the CSRC within three business days after the completion of the offering.
Key Dates
| Date | Description |
|---|---|
| 2021-09-20 | Mingteng International was incorporated. |
| 2022-02-15 | The Cybersecurity Review Measures became effective. |
| 2023-03-31 | The Trial Measures came into effect. |
| 2023-09-25 | Mingteng International received approval from the CSRC regarding completion of required filing procedures for its IPO. |
| 2024-02-24 | The last reported sales price of the company's Ordinary Shares on the Nasdaq Capital Market was US$5.68 per share. |
| 2024-04-22 | The company completed its IPO. |
| 2025-03-14 | The last reported sales price of the company's Ordinary Shares on the Nasdaq Capital Market was US$5.68 per share. |
| [--], 2025 | Date of the prospectus. |
Keywords
Ordinary Shares, Pre-Funded Warrants, Offering, Mingteng International, Placement Agents, Securities, China, CSRC, HFCAA, PCAOB, Auditors, Dividends, Risk Factors, Prospectus
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.